Hydrozide 25 Tablet contains Hydrochlorothiazide 25 mg, a thiazide diuretic primarily used in the management of hypertension and edema associated with congestive heart failure, liver cirrhosis, and renal disorders. Hydrochlorothiazide acts by inhibiting sodium reabsorption in the distal convoluted tubules of the nephron, promoting increased excretion of sodium and water, thereby reducing plasma volume and peripheral vascular resistance. This mechanism contributes to its antihypertensive and diuretic effects. Hydrozide 25 is indicated for patients requiring effective blood pressure control or fluid volume reduction. The onset of diuretic action typically occurs within 2 hours, with peak effects around 4 hours and duration lasting up to 12 hours. Caution is advised in patients with renal impairment, electrolyte imbalances, or gout, as Hydrochlorothiazide may cause hypokalemia, hyponatremia, hyperuricemia, and hyperglycemia. Regular monitoring of electrolytes, renal function, and blood pressure is recommended during therapy. Concomitant use with other antihypertensives may enhance blood pressure-lowering effects but requires careful dose adjustment. Hydrozide 25 should be taken orally, preferably in the morning to avoid nocturia. It is contraindicated in patients with anuria or hypersensitivity to sulfonamide-derived drugs. Proper medical supervision is essential to optimize therapeutic outcomes and minimize adverse effects.